Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer

M. Timmermans*, N. Zwakman, G. S. Sonke, K. K. Van de Vijver, M. J. Duk, M. A. van der Aa, R. F. Kruitwagen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)364-369
Number of pages6
JournalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
Volume240
DOIs
Publication statusPublished - Sep 2019

Keywords

  • Epithelial ovarian cancer
  • CA125
  • Surgery
  • Chemotherapy
  • Overall survival
  • ADVANCED-STAGE OVARIAN
  • GROSS RESIDUAL DISEASE
  • PRIMARY SURGERY
  • SURVIVAL
  • CYTOREDUCTION
  • TUMORIGENESIS
  • CHEMOTHERAPY
  • THERAPY
  • ASCITES
  • DECLINE

Cite this